1. Targeting pyroptosis to regulate ischemic stroke injury: Molecular mechanisms and preclinical evidences
   Anqi Ye et al, 2020, Brain Research Bulletin CrossRef
2. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children
   Feng Jiang et al, 2021, Journal of Immunology Research CrossRef
3. MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin
   Yakun Luo et al, 2021, J Exp Clin Cancer Res CrossRef
4. The multifaceted roles of gasdermins in cancer biology and oncologic therapies.
   David Sarrió et al, 2021, Biochim Biophys Acta Rev Cancer CrossRef
5. P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer
   Qi Zhao et al, 2021, Front. Cell Dev. Biol. CrossRef
6. The role of pyroptosis in lung cancer and compounds regulated pyroptosis of lung cancer cells
   Feng Tian et al, 2021, J Can Res Ther CrossRef
7. A Multi-Omics Approach to Evaluate the Toxicity Mechanisms Associated with Silver Nanoparticles Exposure
   Guillermo Aragoneses-Cazorla et al, 2022, Nanomaterials CrossRef
8. Role of Pyroptosis in Gynecological Oncology and Its Therapeutic Regulation
   Yi Huang et al, 2022, Biomolecules CrossRef
9. Establishment of a prognostic signature for lung adenocarcinoma by integration of 7 pyroptosis-related genes and cross-validation between the TCGA and GEO cohorts: A comprehensive bioinformatics analysis
   Wei Zhang et al, 2022 CrossRef
10. Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions
    Wei Peng et al, 2022 CrossRef
11. Construction and Validation of an Oxaliplatin-Resistant Gene Signature in Colorectal Cancer Patients Who Underwent Chemotherapy
    Yixin Yin et al, 2022, Pharmaceuticals CrossRef
12. Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
    Yang Yang et al, 2022, Sig Transduct Target Ther CrossRef
13. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes
    Xiaheng Deng et al, 2022 CrossRef
14. The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy
    Hua Wang et al, 2022, J Hematol Oncol CrossRef
15. Pyroptosis: A new insight of non-small-cell lung cancer treatment
    Xi Chen et al, 2022, Front. Oncol. CrossRef
16. Gasdermins and pannexin-1 mediate pathways of chemotherapy-induced cell lysis in hematopoietic malignancies
    Bowen Zhou et al, 2022, Sci. Signal. CrossRef
17. P4HA1 activates HMGCS1 to promote nasopharyngeal carcinoma ferroptosis resistance and progression
    Rui Zhou et al, 2023, Cellular Signalling CrossRef
18. P4HA1, transcriptionally activated by STAT1, promotes esophageal cancer progression
    Wenbin Gou et al, 2023, Pathology International CrossRef
19. Prognostic Value and Immunological Role of P4HA3 in Colon Adenocarcinoma
    Jun Huang et al, 2023, IJGM CrossRef
20. Pyroptosis: A promising target for lung cancer therapy
    Wensheng Zhou et al, 2023, Chinese Medical Journal Pulmonary and Critical Care Medicine CrossRef
21. Effects of hsa_circ_0074854 on colorectal cancer progression, construction of a circRNA–miRNA–mRNA network, and analysis of immune infiltration
    Guida Fang et al, 2023, J Cancer Res Clin Oncol CrossRef
22. Pyroptosis and inflammasomes in cancer and inflammation
    Jie‐Lin Wang et al, 2023, MedComm CrossRef
23. New prospects of cancer therapy based on pyroptosis and pyroptosis inducers
    Qiaoyun Chen et al, 2023, Apoptosis CrossRef
24. The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles
    Yixiang Hu et al, 2023, Cell Death Dis CrossRef
25. Identification of a Hypoxia-Related Signature as Candidate Detector for Schizophrenia Based on Genome-Wide Gene Expression
    Zhitao Li et al, 2023, Hum Hered CrossRef
26. Multilevel chitosan–gelatin particles loaded with P4HA1 siRNA suppress glioma development
    Yiting Zhou et al, 2024, Drug Deliv. and Transl. Res. CrossRef
27. Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors
    Julia Krushkal et al, 2024, Epigenetics CrossRef
28. Boningmycin induces AMPK-mediated endoplasmic reticulum-associated degradation of PD-L1 protein in human cancer cells
    Juan Zhang et al, 2023, International Immunopharmacology CrossRef
29. The up‐regulation of PD‐L1 during boningmycin‐induced senescence in human cancer cells depends on the activation of the JAK/STAT signaling pathway mediated by SASP
    Yang Chen et al, 2024, Immunol Cell Biol CrossRef
30. Integrative and Comprehensive Pan-Cancer Analysis of Lymphocyte-Specific Protein Tyrosine Kinase in Human Tumors
    Mingwei Han et al, 2022, IJMS CrossRef
31. Pyroptosis and chemical classification of pyroptotic agents
    Mohammed A. Hara et al, 2024, Mol Divers CrossRef
32. Pyroptosis‐related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma
    Yi Zhang et al, 2024, Molecular Carcinogenesis CrossRef
33. P4HA1: an important target for treating fibrosis related diseases and cancer
    Xuewen Yang et al, 2024, Front. Pharmacol. CrossRef